U.S. Markets close in 2 hrs 14 mins
  • S&P 500

    4,410.13
    +12.19 (+0.28%)
     
  • Dow 30

    34,364.50
    +99.10 (+0.29%)
     
  • Nasdaq

    13,855.10
    +86.23 (+0.63%)
     
  • Russell 2000

    1,987.92
    -36.12 (-1.78%)
     
  • Crude Oil

    0 (0)
     
  • Gold

    1,841.10
    -0.60 (-0.03%)
     
  • Silver

    24.34
    -0.37 (-1.50%)
     
  • EUR/USD

    1.1348
    +0.0031 (+0.2724%)
     
  • 10-Yr Bond

    1.7350
    -0.0120 (-0.69%)
     
  • Vix

    28.85
    +3.26 (+12.74%)
     
  • GBP/USD

    1.3555
    -0.0045 (-0.3321%)
     
  • USD/JPY

    113.6500
    -0.4500 (-0.3944%)
     
  • BTC-USD

    37,331.11
    +1,420.53 (+3.96%)
     
  • CMC Crypto 200

    823.79
    +13.18 (+1.63%)
     
  • FTSE 100

    7,494.13
    -90.88 (-1.20%)
     
  • Nikkei 225

    27,522.26
    -250.64 (-0.90%)
     

Petco Health + Wellness Company, Inc. announces record revenue and earnings with 20 percent comp growth and 30 percent on a two-year basis

  • Oops!
    Something went wrong.
    Please try again later.
·24 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • WOOF

- Recurring revenue offerings, rapidly expanding vet business and digital growth drive eleventh consecutive quarter of comparable sales growth

- Revenue growth of 19 percent year over year and 31 percent on a two-year basis

- Earnings per share of $0.28; Adjusted Earnings Per Share1 of $0.25

- Raised full year 2021 guidance on top and bottom line

SAN DIEGO, Aug. 19, 2021 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, today released its financial results for its second quarter ended July 31, 2021.

Petco logo (PRNewsfoto/Petco Health and Wellness Company, Inc.)
Petco logo (PRNewsfoto/Petco Health and Wellness Company, Inc.)

In the second quarter of 2021, Petco delivered net revenue of $1.4 billion, up 19 percent versus prior year. Net income improved by $67.7 million from prior year to $75.1 million or $0.28 per share. Trailing twelve month net income improved by $139.0 million from prior year to $79.9 million. Adjusted Net Income1 increased $44.4 million from prior year to $67.5 million or $0.25 per share, while second quarter Adjusted EBITDA1 increased by 19 percent from prior year to $155.1 million.

"With purpose driven performance at the heart of all we do, our second quarter results reflect the strength of our differentiated model and continued focus on driving customer acquisition, increasing spend, fueling comp growth of 20 percent year-over-year and 30 percent on a two-year stack," said Ron Coughlin, Chairman and Chief Executive Officer of Petco. "We exited Q2 with strong momentum while lapping robust double-digit comp growth. Looking ahead, we're operating from a position of strength as we move into the second half, which gave us the confidence to raise our guidance. We believe we have significant runway for continued growth as we execute against our proven transformation strategy in multi-year growth areas across services, veterinary care, digital, and owned and premium brands."

Additionally, in the first half of 2021 total debt remained roughly flat at $1.7 billion with Net Debt1 improving $73.4 million to $1.5 billion driven by net cash flow from operations of $202.4 million and Free Cash Flow1 of $102.5 million, up 119 percent and 142 percent, respectively, from the first half of 2020. Also in the first half of 2021, Net Debt1 / Trailing Twelve Month Adjusted EBITDA1 decreased 16 percent or 0.5x to 2.7x driven by Free Cash Flow1 generation and growth in Adjusted EBITDA1.

Fiscal Q2 2021 Highlights:
Comparisons are second quarter of 2021 ended July 31, 2021 versus second quarter of 2020 ended August 1, 2020 unless otherwise noted

  • Net revenue increased 19 percent to $1.4 billion driven by comp sales growth of 20 percent

  • Net income increased $67.7 million to $75.1 million or $0.28 per share

  • Adjusted Net Income1 increased $44.4 million to $67.5 million or $0.25 per share

  • Adjusted EBITDA1 increased 19 percent to $155.1 million, excluding a $45.2 million gain from mark to market on our investment in A Place for Rover, Inc4

  • Trailing twelve month net income increased $139.0 million to $79.9 million

  • Trailing Twelve Month Adjusted EBITDA increased $98.2 million to $547.5 million

  • Net cash provided by operating activities increased $110.0 million to $202.4 million in the first half of the 2021

  • Free Cash Flow1 increased $60.2 million to $102.5 million in the first half of 2021

  • Total debt decreased $1.6 billion or 49 percent to $1.7 billion driven by the proceeds generated in the company's initial public offering, related recapitalization, and Free Cash Flow1 generation

  • Net Debt1 decreased $1.6 billion or 52 percent to $1.5 billion

  • Net Debt1 / Trailing Twelve Month Adjusted EBITDA1 improved 61 percent to 2.7x

  • Liquidity of $644.5 million inclusive of $203.4 million of cash and cash equivalents and $441.1 million of availability on revolving credit facility

  • Ended the quarter with 1,451 Pet Care Centers, 155 Full Service Vet Hospitals within Pet Care Centers, and 101 Pet Care Centers in Mexico

Fiscal 2021 Guidance:

The following guidance as of August 19, 2021 reflects the company's expectations for fiscal year 2021 unless otherwise indicated.

Metric

Current Guidance

Prior Guidance

Net Revenue

$5.6 billion-$5.7 billion

$5.475 billion-$5.575 billion

Adjusted EBITDA2

$565 million-$575 million

$550 million-$560 million

Adjusted EPS2

$0.81-$0.85

$0.73-$0.76

Capital Expenditures3

Near top of prior range

$185 million-$235 million

Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. The company continues to monitor those assumptions and any potential financial impacts. Adjusted EPS guidance assumes approximately $80 million of interest expense, a 26 percent tax rate and 266 million weighted average diluted share count.

(1)

Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, Free Cash Flow, Net Debt, and Trailing Twelve Month Adjusted EBITDA are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

(2)

We have not reconciled Adjusted EBITDA and Adjusted EPS outlook as non-GAAP measures to the most comparable GAAP measures because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlooks for the comparable GAAP measures. Forward–looking estimates of Adjusted EBITDA and Adjusted EPS are estimated in a manner consistent with the relevant definitions and assumptions noted herein.

(3)

Original capital expenditure guidance was given in the 10-K.

(4)

In July 2021, the company recognized a $45.2 million gain from the remeasurement of the fair value of its investment in A Place for Rover, Inc. ("Rover") following Rover's completion of a business combination with Nebula Caravel Acquisition Corp., a publicly-traded special purpose acquisition company.

Earnings Conference Call Webcast Information:

The company will host an earnings conference call on August 19, 2021 at 8:30 AM Eastern Time to discuss Petco's financial results. The conference call will be accessible through live webcast. Interested investors and other individuals can access the webcast, earnings press release, and earnings presentation via the company's investor relations page at ir.petco.com/investor-relations. A replay of the webcast will be archived on the company's website through September 2, 2021 at 5:00 PM Eastern Time.

About Petco, The Health + Wellness Co.:

Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. Since our founding in 1965, we've been striving to set new standards in pet care, delivering comprehensive wellness solutions through our products and services, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 Petco locations across the U.S., Mexico and Puerto Rico, including a growing network of more than 150 in-store veterinary hospitals, and offer a complete online resource for pet health and wellness at petco.com and on the Petco app. In tandem with Petco Love (formerly the Petco Foundation), an independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we've helped find homes for more than 6.5 million animals.

Forward-Looking Statements:

This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including statements regarding our environmental and other sustainability plans and goals, and potential acquisitions, investments and dispositions. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct. There can be no assurance that any forward-looking results will occur or be realized, and nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. Such forward-looking statements can be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative", or the negative thereof or other variations thereon or comparable terminology. All forward-looking statements are based on assumptions or judgments about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results to differ materially from the potential results discussed in the forward-looking statements, including, without limitation, those identified in this earnings release, the risk factors that Petco identifies in its Securities and Exchange Commission filings, as well as the following: (i) increased competition (including from multi-channel retailers and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a privacy or security breach; (x) our ability to effectively manage strategic ventures, alliances or acquisitions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) interruptions and other supply chain issues; (xiii) catastrophic events, health crises, and pandemics, including the potential effects that the ongoing COVID-19 pandemic and/or corresponding macroeconomic uncertainty could have on our financial position, results of operations and cash flows; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; and (xix) changes in our credit ratings. The occurrence of any such factors, events, or circumstances would significantly alter the results set forth in these statements.

Petco cautions that the foregoing list of important factors is not complete, and any forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any forward-looking statement that it may make, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited and subject to reclassification)











13 Weeks Ended




July 31,
2021


August 1,
2020


Percent
Change


Net sales


$ 1,434,534


$ 1,208,971


19%


Cost of sales


835,124


679,218


23%


Gross profit


599,410


529,753


13%


Selling, general and administrative expenses


525,942


464,706


13%


Operating income


73,468


65,047


13%


Interest income


(13)


(99)


(87%)


Interest expense


19,206


54,493


(65%)


Other non-operating income


(45,162)



N/M


Income before income taxes and income from
equity method investees


99,437


10,653


833%


Income tax expense


27,011


4,958


445%


Income from equity method investees


(2,429)


(745)


226%


Net income


74,855


6,440


1062%


Net loss attributable to noncontrolling interest


(256)


(1,001)


(74%)


Net income attributable to Class A and B-1 common
stockholders


$ 75,111


$ 7,441


909%










Net income per Class A and B-1 common share:








Basic


$ 0.28


$ 0.04


699%


Diluted


$ 0.28


$ 0.04


696%










Weighted average shares used in computing net income per Class A
and B-1 common share:








Basic


264,216


209,015


26%


Diluted


265,217


209,015


27%


PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Q2 2021 unaudited and subject to reclassification)






July 31,
2021


January 30,
2021

ASSETS





Current assets:





Cash and cash equivalents


$ 203,404


$ 111,402

Receivables, less allowance for credit losses1


39,889


41,827

Merchandise inventories, net


628,491


538,675

Prepaid expenses


41,990


40,032

Other current assets


30,381


45,613

Total current assets


944,155


777,549

Fixed assets


1,586,677


1,487,987

Less accumulated depreciation


(932,283)


(860,440)

Fixed assets, net


654,394


627,547

Operating lease right-of-use assets


1,314,533


1,328,108

Goodwill


2,182,465


2,179,310

Trade name


1,025,000


1,025,000

Other intangible assets


4,793


4,793

Less accumulated amortization


(4,251)


(4,079)

Other intangible assets, net


542


714

Other long-term assets


194,092


137,474

Total assets


$ 6,315,181


$ 6,075,702

LIABILITIES AND EQUITY





Current liabilities:





Accounts payable and book overdrafts


$ 406,685


$ 339,485

Accrued salaries and employee benefits


123,721


129,484

Accrued expenses and other liabilities


210,517


145,846

Current portion of operating lease liabilities


248,631


258,289

Current portion of long-term debt and other lease liabilities


20,235


2,203

Total current liabilities


1,009,789


875,307

Senior secured credit facilities, net, excluding current portion


1,646,463


1,646,281

Operating lease liabilities, excluding current portion


1,070,063


1,083,575

Deferred taxes, net


293,611


280,920

Other long-term liabilities


135,873


134,354

Total liabilities


4,155,799


4,020,437

Commitments and contingencies





Stockholders' equity:





Class A common stock2


226


226

Class B-1 common stock3


38


38

Class B-2 common stock4



Preferred stock5



Additional paid-in-capital


2,115,220


2,092,110

Retained earnings (accumulated deficit)


60,420


(22,251)

Accumulated other comprehensive loss


(1,272)


(1,275)

Total stockholders' equity


2,174,632


2,068,848

Noncontrolling interest


(15,250)


(13,583)

Total equity


2,159,382


2,055,265

Total liabilities and equity


$ 6,315,181


$ 6,075,702



(1)

Allowances for credit losses are $1,802 as of July 31, 2021 and $3,267 as of Jan 30, 2021

(2)

Class A common stock, par value $0.001 per share (1.0 billion shares authorized and 226.5 million shares issued and outstanding as of July 31, 2021 and 226.4 million shares issued and outstanding as of January 30, 2021)

(3)

Class B-1 common stock, par value $0.001 per share (75.0 million shares authorized and 37.8 million shares issued and outstanding)

(4)

Class B-2 common stock, par value $0.000001 per share (75.0 million shares authorized and 37.8 million shares issued and outstanding)

(5)

Preferred stock, par value $0.001 per share (25.0 million shares authorized and no shares issued or outstanding)

PETCO HEALTH AND WELLNESS COMPANY, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited and subject to reclassification)








26 Weeks Ended



July 31,
2021


August 1,
2020

Cash flows from operating activities:





Net income (loss)


$ 81,004


$ (26,932)

Adjustments to reconcile net income (loss) to net cash provided by
operating activities:





Depreciation and amortization


82,845


86,038

Amortization of debt discounts and issuance costs


3,369


12,125

Provision for deferred taxes


12,691


(21,753)

Equity-based compensation


23,110


4,617

Impairments, write-offs and losses on sale of fixed and other assets


2,690


6,261

Loss on extinguishment and modification of debt


20,838


Income from equity method investees


(4,854)


(1,077)

Amounts reclassified out of accumulated other comprehensive income



5,066

Change in contingent consideration obligation



(391)

Non-cash operating lease costs


210,490


216,729

Other non-operating income


(45,162)


Changes in assets and liabilities:





Receivables


1,937


(5,208)

Merchandise inventories


(89,784)


(11,056)

Prepaid expenses and other assets


3,294


(9,153)

Accounts payable and book overdrafts


74,466


(18,955)

Accrued salaries and employee benefits


(6,017)


3,116

Accrued expenses and other liabilities


51,145


35,747

Operating lease liabilities


(220,655)


(196,700)

Other long-term liabilities


997


13,915

Net cash provided by operating activities


202,404


92,389

Cash flows from investing activities:





Cash paid for fixed assets


(99,883)


(50,043)

Cash paid for acquisitions, net of cash acquired


(2,807)


Distributions from equity investees



73

Proceeds from sale of assets


105


1,296

Net cash used in investing activities


(102,585)


(48,674)

Cash flows from financing activities:





Borrowings under long-term debt agreements


1,700,000


440,000

Repayments of long-term debt


(1,682,361)


(456,625)

Debt refinancing costs and original issue discount


(24,665)


Payments for finance lease liabilities


(2,044)


(2,089)

Proceeds from employee stock purchase plan


1,721


Repurchase of equity



(105)

Payment of contingent consideration



(250)

Payment of offering costs


(3,844)


Net cash used in financing activities


(11,193)


(19,069)






Net increase in cash, cash equivalents and restricted cash


88,626


24,646

Cash, cash equivalents and restricted cash at beginning of period


119,540


154,718

Cash, cash equivalents and restricted cash at end of period


$ 208,166


$ 179,364

NON-GAAP FINANCIAL MEASURES

The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in the earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in the earnings release. The non-GAAP financial measures in the earnings release may differ from similarly titled measures used by other companies.

Adjusted EBITDA

Adjusted EBITDA, including Trailing Twelve Month Adjusted EBITDA, is considered a non-GAAP financial measure under the SEC's rules because it excludes certain charges included in net income (loss) calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it best allows comparison of the current period performance with that of the comparable period. In addition, Adjusted EBITDA affords investors a view of what management considers Petco's operating performance to be as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period.

Please see the company's 10-K filed on April 5, 2021 for additional information on the reconciliation of Net Income (Loss) Attributable to Class A and B-1 Common Stockholders to Adjusted EBITDA. The tables below reflect the calculation of Adjusted EBITDA for the thirteen weeks and trailing twelve months ended July 31, 2021 compared to the prior year quarter and twelve-month period ended August 1, 2020, respectively, as well as the twelve month period ended January 30, 2021.

(Dollars in thousands)


13 Weeks Ended


Reconciliation of Net Income Attributable to Class A and B-1
Common Stockholders to Adjusted EBITDA


July 31,
2021


August 1,
2020


Net income attributable to Class A and B-1 common stockholders


$ 75,111


$ 7,441


Add (deduct):






Interest expense, net


19,193


54,394


Income tax expense


27,011


4,958


Depreciation and amortization


41,238


42,471


Income from equity method investees


(2,429)


(745)


Asset impairments and write offs


1,743


2,852


Equity-based compensation


11,506


2,312


Other non-operating income


(45,162)



Mexico joint venture EBITDA (1)


5,856


3,483


Store pre-opening expenses


3,488


1,477


Store closing expenses


962


2,609


Non-cash occupancy-related costs (2)


2,885


5,969


Non-recurring costs (3)


13,671


3,591


Adjusted EBITDA


$ 155,073


$ 130,812


Net sales


$ 1,434,534


$ 1,208,971


Net margin (4)


5.2%


0.6%


Adjusted EBITDA Margin


10.8%


10.8%










(Dollars in thousands)


Trailing Twelve Months


Reconciliation of Net Income (Loss) Attributable to Class A and B-1
Common Stockholders to Adjusted EBITDA


July 31,
2021


January 30,
2021


August 1,
2020


Net income (loss) attributable to Class A and B-1 common stockholders


$ 79,915


$ (26,483)


$ (59,117)


Add (deduct):








Interest expense, net


143,113


218,430


238,799


Income tax expense (benefit)


31,950


(3,337)


(21,439)


Depreciation and amortization


171,643


174,836


173,968


Income from equity method investees


(10,259)


(6,482)


(3,080)


Loss on debt extinguishment and modification


38,387


17,549



Goodwill & indefinite-lived intangible impairment




19,000


Asset impairments and write offs


12,035


15,606


12,448


Equity-based compensation


31,408


12,915


9,854


Other non-operating income


(45,162)




Mexico joint venture EBITDA (1)


23,434


19,074


15,582


Store pre-opening expenses


13,360


9,228


8,257


Store closing expenses


6,211


7,782


7,110


Non-cash occupancy-related costs (2)


10,095


19,240


26,684


Non-recurring costs (3)


41,389


25,990


21,285


Adjusted EBITDA


$ 547,519


$ 484,348


$ 449,351


Net sales


$ 5,447,238


$ 4,920,202


$ 4,564,217


Net margin (4)


1.5%


(0.5%)


(1.3%)


Adjusted EBITDA Margin


10.1%


9.8%


9.8%


Adjusted Net Income and Adjusted EPS

Adjusted Net Income and Adjusted diluted earnings per share attributable to Petco (Adjusted Net Income and Adjusted EPS respectively) are considered non-GAAP financial measures under the SEC's rules because they exclude certain amounts included in the net income (loss) attributable to common stockholders and diluted earnings per share attributable to Petco calculated in accordance with GAAP (net income (loss) and EPS respectively), the most directly comparable financial measures calculated in accordance with GAAP. Management believes that Adjusted Net Income and Adjusted EPS are meaningful measures to share with investors because they best allow comparison of the current period performance with that of the comparable period. In addition, Adjusted Net Income and Adjusted EPS afford investors a view of what management considers Petco's earnings performance to be as well as the ability to make a more informed assessment of such earnings performance with that of the prior period.

The tables below reflect the calculation of Adjusted Net Income (Loss) and Adjusted EPS for the thirteen weeks ended July 31, 2021 compared to the prior year quarter ended August 1, 2020.

(In thousands, except per share amounts)


13 Weeks Ended

Reconciliation of Diluted EPS to Adjusted EPS


July 31, 2021


August 1, 2020



Amount


Per share


Amount


Per share

Net income attributable to common stockholders / diluted EPS


$ 75,111


$ 0.28


$ 7,441


$ 0.04

Add (deduct):









Income tax expense


27,011


0.10


4,958


0.02

Asset impairments and write offs


1,743


0.01


2,852


0.01

Equity-based compensation


11,506


0.04


2,312


0.01

Other non-operating income


(45,162)


(0.17)



Store pre-opening expenses


3,488


0.01


1,477


0.01

Store closing expenses


962


0.01


2,609


0.01

Non-cash occupancy-related costs (2)


2,885


0.01


5,969


0.03

Non-recurring costs (3)


13,671


0.05


3,591


0.02

Adjusted pre-tax income / diluted earnings per share


$ 91,215


$ 0.34


$ 31,209


$ 0.15

Income tax expense at 26% normalized tax rate


23,716


0.09


8,114


0.04

Adjusted Net Income / Adjusted EPS


$ 67,499


$ 0.25


$ 23,095


$ 0.11

Free Cash Flow

Free Cash Flow is a non-GAAP financial measure that is calculated as net cash generated by operations less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.

Although other companies report their Free Cash Flow, numerous methods exist for calculating a company's Free Cash Flow. As a result, the method used by Petco's management to calculate Free Cash Flow may differ from the methods used by other companies to calculate their Free Cash Flow.

The following table sets forth a reconciliation of Free Cash Flow to net cash provided by (used in) operating activities, which Petco believes to be the GAAP financial measure most directly comparable to Free Cash Flow. The table below reflects the calculation of Free Cash Flow for the thirteen and twenty six weeks ended July 31, 2021 compared to the thirteen and twenty six weeks ended August 1, 2020.

(in thousands)


13 Weeks Ended


26 Weeks Ended



July 31,
2021


August 1,
2020


July 31,
2021


August 1,
2020

Net cash provided by operating activities


$ 87,402


$ 124,678


$ 202,404


$ 92,389

Cash paid for fixed assets


(52,532)


(22,148)


(99,883)


(50,043)

Free Cash Flow


$ 34,870


$ 102,530


$ 102,521


$ 42,346

Net Debt

Net Debt is a non-GAAP financial measure that is calculated as the sum of current and non-current debt, less cash and cash equivalents. Management considers this adjustment useful because it reduces the volatility of total debt caused by fluctuations between cash paid against the company's revolving credit facility and cash held on hand in cash and cash equivalents.

Although other companies report their Net Debt, numerous methods exist for calculating a company's Net Debt. As a result, the method used by Petco's management to calculate Net Debt may differ from the methods used by other companies to calculate their Net Debt.

The following table sets forth a reconciliation of Net Debt, to total debt, which Petco believes to be the GAAP financial measure most directly comparable to Net Debt. The table below reflects the calculation of Net Debt as of the period ended July 31, 2021 compared to the prior quarters ended January 30, 2021 and August 1, 2020.

(Dollars in thousands)


July 31,
2021


January 30,
2021


August 1,
2020

Total debt:







Senior secured credit facilities, net, including current portion


$ 1,663,463


$ 1,646,281


$ 2,381,419

Senior notes, net




867,778

Finance leases, including current portion


15,104


13,639


14,347

Total debt


1,678,567


1,659,920


3,263,544

Less: cash and cash equivalents


(203,404)


(111,402)


(168,892)

Net Debt


$ 1,475,163


$ 1,548,518


$ 3,094,652

Adjusted EBITDA (TTM)


$ 547,519


$ 484,348


$ 449,351

Net Debt / Adjusted EBITDA ratio


2.7x


3.2x


6.9x

Adjusted EBITDA, Adjusted Net Income and Adjusted EPS Footnotes



(1)

Mexico Joint Venture EBITDA represents 50 percent of the entity's operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes. Because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company's Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.





13 Weeks Ended

(in thousands)


July 31,
2021


August 1,
2020

Net income


$ 4,864


$ 2,384

Depreciation


3,401


$ 2,702

Income tax expense


2,631


$ 1,129

Foreign currency gain


(342)


$ (295)

Interest expense, net


1,158


$ 1,046

EBITDA


$ 11,712


$ 6,966

50% of EBITDA


$ 5,856


$ 3,483



(2)

Non-cash occupancy-related costs include the difference between cash and straight-line rent for all periods.



(3)

Non-recurring costs include: severance; legal reserves and related fees; one-time consulting and other costs associated with our strategic transformation initiatives; discontinuation and liquidation costs; and costs related to the initial public offering and refinancing. While we incurred significant costs associated with the COVID-19 pandemic during fiscal 2020, we have not classified any of these costs as non-recurring due to the uncertainty surrounding the pandemic's length and long-term impact on the macroeconomic operating environment.



(4)

We define net margin as net income (loss) attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

WOOF-F

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-health--wellness-company-inc-announces-record-revenue-and-earnings-with-20-percent-comp-growth-and-30-percent-on-a-two-year-basis-301358562.html

SOURCE Petco Health and Wellness Company, Inc.